CASE STUDY Presentation Outline: Background Case Summary What is ‘crisis management’? Strategic Phase Reactive Phase Image Restoration Lessons Learnt Background: GlaxoSmithKline (GSK) is a British multinational pharmaceutical and consumer healthcare company that operates in over 100 countries. They have an extensive portfolio of products for major disease areas including asthma‚ cancer‚ infection‚ diabetes and digestive conditions Some products they produce that you might be familiar
Free Crisis management Management
Financial statements P102–P191 Shareholder information P192–P212 Business review 2010 Performance overview Research and development Pipeline summary Products‚ competition and intellectual property Regulation Manufacturing and supply World market GSK sales performance Segment reviews Responsible business Financial review 2010 Financial position and resources Financial review 2009 Risk factors Governance and remuneration Our Board Our Corporate Executive Team Governance and policy Dialogue with shareholders
Premium Vaccine Rate of return Clinical trial
Case study C: GSK‚ a merger too far? 1- Derive three opportunities and three threats for GSK by first making the PESTEL analysis of the macro-environment surrounding the pharmaceutical industry. (9 points) * PESTEL analysis of the pharmaceutical industry: Political: Since the creation of healthcare insurance‚ companies have to conform themselves to two kinds of systems: 1) The universal system applied for example in France‚ with less demand in new technologies. 2) The very selective anglo-saxon
Premium Pharmacology Generic drug Pharmaceutical industry
1. INTEPRETATONS OF FINANCIAL RATIOS A. GlaxoSmithKline at a glance. “GlaxoSmithKline (GSK) is a global healthcare company specialized in the discovery‚ development‚ manufacturing and marketing pharmaceutical and consumer health-related products. GSK has operations in about 114 countries‚ with products being sold in over 150 countries”. A. Evaluation of profitability ratios. For the evaluation of the profitability ratio over five-year period we will analyse the
Premium Financial ratios Financial ratio
name] GSK – Successful Internal Innovation Question 1 Based on GSK’s past performance‚ what do you believe are the critical implementation issues for GSK with regards to internal innovation? Figure 4‚ 2‚ pg 132‚ The management of technology and innovation (White & Brighton) GSK key reason of success lies in its continuous radical change‚ by constantly inventing new drugs. Critical to the implementation issues of its internal innovation are raised below: Leadership GSK leadership
Premium Control system Control engineering Invention
PROJECT REPORT ON WORKING CAPITAL MANAGEMENT WITH SPECIAL EMPHASIS ON VARIOUS TECHNIQUES OF INVENTORY CONTROL [pic] A training report submitted in partial fulfillment of the requirement for the degree Of MASTERS OF BUSINESS ADMINISTRATION (2010-2012) SUBMITTED TO: SUBMITTED BY:
Premium Inventory Financial ratio
1) Product markets and geographic markets in which GSK is present GSK’s core mission is to “improve the quality of human life by enabling people to do more‚ feel better and live longer”. To achieve this mission‚ they operate in three main areas of businesses: the Pharmaceuticals (£18 Bn in 2012‚ or 68% of their revenues)‚ the Vaccines (£3.3 Bn‚ or 11% or their revenues) and the Consumer Healthcare (£5.1 Bn‚ or 19% of their revenues). In particular‚ the Pharmaceuticals cover medicines to treat a broad
Premium Medicine Pharmacology Food and Drug Administration
Answer 2 …… Glaxosmithkline (GSK )‚ a research and development firm seeking to be excel in internal innovation through research on eight therapy areas- biopharmaceuticals‚ immune-inflammation‚ infectious diseases‚ metabolic pathways‚ neuroscience‚ oncology‚ ophthalmology and respiratory. To address these areas the firm in 2008 created 70 Discovery Performance Unit (DPUs) for future growth of the company. These 70 DPUs can affect the implementation effort in following ways to achieve success in
Premium Research Control theory Innovation
EVALUATION OF THE FINANCIAL PERFORMANCE OF GLAXOSMITHKLINE 2008 AND 2009 BACKGROUND OF THE COMPANY GSK is the world’s largest pharmaceutical company. It has a 7% share of the global pharmaceutical market‚ 26% of all vaccine sales‚ and 17% of all anti-invectives. It was formed with the merger of two top pharmaceutical companies‚ Glaxo Wellcome Plc and SmithKline Beecham Plc in December 2000. “GSK’s history dates back to 1715‚ when Plough Court pharmacy‚ a predecessor to SmithKline Beecham‚ was
Premium Generally Accepted Accounting Principles
The Capability Maturity Models Integration and IT System and Service Acquisition Projects Han Reichgelt School of Computing and Software Engineering Southern Polytechnic State Unversity Overview The purpose of this document is to provide a guide to the Capability Maturity Model Integration for Acquisition (CMMI-ACQ) and the guidebook on using the Capability Maturity Model Integration for Development (CMMI-DEV) in IT system and service acquisition projects. It will provide some general background
Premium Capability Maturity Model